aod9604 steroid AOD 9604 5mg, 10mg Research Peptide with Revive Peptides EU AOD-9604 - LeadWest Medical
Description
AOD-9604 is not FDA-approved for any indication, including joint health or cartilage regeneration
Phase 1 study dosing: Doses tested: 100 mcg to 1000 mcg daily Route: subcutaneous injection Results: dose-proportional effects on fat loss Safety: all doses well tolerated Phase 2 study dosing: Doses tested: 300 mcg to 600 mcg daily Route: once- or twice-daily subcutaneous injection Duration: 12 weeks typical Results: significant fat loss at all doses, with 500600 mcg showing the best efficacy Research Dosage Guidelines Based on available clinical data, research protocols generally consider the following ranges
On the other hand, if you are self-administering, then the thigh is a more convenient location
Not everyone needs these treatments and thats perfectly okay
